Press Release: Mergers: Commission clears proposed acquisition of EBEWE SP by Novartis

The European Commission approved under the EU Merger Regulation the proposed acquisition of the Austrian generic pharmaceuticals company EBEWE Spezial–Pharma Holding by Novartis of Switzerland, a pharmaceutical company with both originator and generic activities. The Commission concluded that the proposed transaction would not significantly impede effective competition in the European Economic Area ('EEA') or any substantial part of it.